Results 241 to 250 of about 2,078,021 (401)

Ro 31‐8220 suppresses bladder cancer progression via enhancing autophagy in vitro and in vivo

open access: yesFEBS Open Bio, EarlyView.
The pan‐protein kinase C inhibitor Ro‐31‐8220 demonstrates potent anti‐bladder cancer effects both in vitro and in vivo by suppressing migration/invasion, inducing apoptosis and crucially activating autophagy, where blocking autophagy with chloroquine reduces its cell‐killing efficacy, suggesting its promise as a novel therapeutic candidate requiring ...
Shengjun Fu   +12 more
wiley   +1 more source

Novel Protein Kinase Inhibitors: SMART Drug Design Technology

open access: yesBioTechniques, 2003
Tomi K. Sawyer   +9 more
doaj   +1 more source

Drug Repurposing and De Novo Drug Discovery of Protein Kinase Inhibitors as New Drugs against Schistosomiasis. [PDF]

open access: yesMolecules, 2022
Pereira Moreira B   +6 more
europepmc   +1 more source

Vinblastine accumulation induced by protein kinase inhibitors in rat ascites hepatoma AH66 cells

open access: gold, 1989
Shinya Wakusawa   +3 more
openalex   +1 more source

High LRIG1 expression predicts lymph node metastasis in patients with uterine cervical cancer

open access: yesFEBS Open Bio, EarlyView.
Lymph node status is crucial in determining treatment for women with early‐stage cervical cancer. We demonstrate that high LRIG1 protein expression in primary tumors can predict lymph node metastases. Our findings support further investigation of LRIG1 as a biomarker to improve staging accuracy and guide treatment decisions in cervical cancer patients.
Pernilla Israelsson   +5 more
wiley   +1 more source

Oncotherapeutic Protein Kinase Inhibitors Associated With Pro-Arrhythmic Liability. [PDF]

open access: yesJACC CardioOncol, 2021
Ye JZ, Hansen FB, Mills RW, Lundby A.
europepmc   +1 more source

Calcium-dependent protein kinases and their selective inhibitors

open access: gold, 1987
Satoshi Matsushima   +3 more
openalex   +1 more source

Home - About - Disclaimer - Privacy